T
78.73
1.40 (1.81%)
| Previous Close | 77.33 |
| Open | 78.71 |
| Volume | 3,189,914 |
| Avg. Volume (3M) | 10,159,063 |
| Market Cap | 13,677,571,072 |
| Price / Earnings (TTM) | 36.62 |
| Price / Sales | 16.29 |
| Price / Book | 50.12 |
| 52 Weeks Range | |
| Earnings Date | 3 Nov 2025 |
| Profit Margin | -88.27% |
| Operating Margin (TTM) | -26.93% |
| Diluted EPS (TTM) | -5.16 |
| Quarterly Revenue Growth (YOY) | 75.40% |
| Total Debt/Equity (MRQ) | 262.96% |
| Current Ratio (MRQ) | 1.71 |
| Operating Cash Flow (TTM) | -193.29 M |
| Levered Free Cash Flow (TTM) | 54.30 M |
| Return on Assets (TTM) | -43.89% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | Tempus AI, Inc. | Bullish | Bullish |
AIStockmoo Score
1.2
| Analyst Consensus | 1.5 |
| Insider Activity | -1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 1.20 |
|
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 43.27% |
| % Held by Institutions | 38.33% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Revolution Growth Management Company, Inc. | 31 Mar 2025 | 1,467,565 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 98.00 (HC Wainwright & Co., 24.48%) | Buy |
| Median | 90.00 (14.32%) | |
| Low | 68.00 (Morgan Stanley, -13.63%) | Buy |
| Average | 86.50 (9.87%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 76.12 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Guggenheim | 26 Sep 2025 | 95.00 (20.67%) | Buy | 78.48 |
| HC Wainwright & Co. | 12 Sep 2025 | 98.00 (24.48%) | Buy | 86.38 |
| 02 Sep 2025 | 90.00 (14.31%) | Buy | 78.34 | |
| BTIG | 20 Aug 2025 | 85.00 (7.96%) | Buy | 73.28 |
| Morgan Stanley | 12 Aug 2025 | 68.00 (-13.63%) | Buy | 66.34 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FUKUSHIMA RYAN | - | 93.08 | -5,000 | -465,400 |
| Aggregate Net Quantity | -5,000 | |||
| Aggregate Net Value ($) | -465,400 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 93.08 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FUKUSHIMA RYAN | Officer | 06 Oct 2025 | Automatic sell (-) | 5,000 | 93.08 | 465,400 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |